← Back to ANGO

AngioDynamics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSFeb 2026Filed 02/04/2026Nov 2025Filed 02/04/2026Aug 2025Filed 02/04/2026Feb 2025Filed 02/04/2026Nov 2024Filed 02/04/2026Aug 2024Filed 02/04/2026Feb 2024Filed 02/04/2025Nov 2023Filed 02/04/2025
$78$79$76$72$73$67$75$79
−$8.1−$6.4−$11−$4.4−$11−$13−$188−$29
−$0.19−$0.15−$0.26−$0.11−$0.26−$0.31−$4.67−$0.72
4242414141414040

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.